Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
This is a Phase 2, double-blind, placebo-controlled, two-way crossover study to compare the efficacy of ALTO-101T versus placebo in change in electroencephalogram (EEG) cognitive processing markers and measures of cognition. Additional goals are to assess pharmacokinetic (PK), safety, and tolerability of the recently developed ALTO-101T transdermal delivery system (TDS) formulation in a patient population.
Sponsor: Alto Neuroscience
Check if you qualify for this schizophrenia clinical trial in Los Angeles, CA
If you're searching for schizophrenia treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.